Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Nikola Zagorec"'
Autor:
Ana Šavuk, Danijela Grizelj, Tomo Svaguša, Melanie-Ivana Čulo, Nikola Zagorec, Sara Šakota, Biserka Orehovec, Tomislav Kelava, Ana Livun, Ivan Marković, Josip Baković, Tatjana Kereš
Publikováno v:
Türk Biyokimya Dergisi, Vol 49, Iss 3, Pp 368-376 (2024)
COVID-19 in it is more severe form is characterized by a hyperinflammatory condition, hypercoagulation state and the appearance of pulmonary microembolism. In this study we wanted to correlate levels of D-Dimer, protein C, protein S and antithrombin
Externí odkaz:
https://doaj.org/article/0941909ae4ec4cf59d2b136c79f770f9
Autor:
Dino Kasumović, Nikola Zagorec, Miroslav Tišljar, Ivica Horvatić, Petar Šenjug, Danica Galešić Ljubanović, Krešimir Galešić
Publikováno v:
Liječnički vjesnik, Vol 146, Iss 7-8, Pp 291-298 (2024)
Trombotična mikroangiopatija (TMA) je patohistološki entitet obilježen stvaranjem tromba u mikrocirkulaciji, a klinički se definira posljedičnom mikroangiopatskom hemolitičkom anemijom (MAHA) i trombocitopenijom uz oštećenje ciljnih organa, n
Externí odkaz:
https://doaj.org/article/2112848cf78740899ca5cc231e10b17a
Autor:
Petar Šenjug, Matija Horaček, Bojana Maksimović, Ksenija Vučur, Ivica Horvatić, Nikola Zagorec, Mladen Knotek, Danica Galešić Ljubanović
Publikováno v:
Acta Clinica Croatica, Vol 60., Iss Supplement 1, Pp 133-141 (2021)
Aim. To investigate morphological findings of zero-time biopsies analyzed at the Department of Nephropathology and Electron Microscopy, Dubrava University Hospital, Zagreb. Materials and methods. The retrospective search of data was performed for t
Externí odkaz:
https://doaj.org/article/ec57056066bf4b96a442ad8e451a9ccd
Autor:
Ana, Šavuk, Danijela, Grizelj, Tomo, Svaguša, Melanie-Ivana, Čulo, Nikola, Zagorec, Sara, Šakota, Biserka, Orehovec, Tomislav, Kelava, Ana, Livun, Ivan, Marković, Josip, Baković, Tatjana, Kereš
Publikováno v:
Turkish Journal of Biochemistry / Turk Biyokimya Dergisi; Jun2024, Vol. 49 Issue 3, p368-376, 9p
Autor:
Nikola Zagorec, Martin Bojić, Dino Kasumović, Petar Šenjug, Danica Galešić Ljubanović, Krešimir Galešić, Ivica Horvatić
Publikováno v:
Clinical Kidney Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::196d4effad9881804448ede04c0aabc5
https://doi.org/10.1093/ckj/sfad056
https://doi.org/10.1093/ckj/sfad056
Autor:
Marko Lucijanić, Nevenka Piskač Živković, Marko Zelenika, Mislav Barišić-Jaman, Ivana Jurin, Ana Matijaca, Nikola Zagorec, Marko Lagančić, Besa Osmani, Iva Bušić, Sara Šakota, Ivan Vukoja, Ivica Lukšić, Bruno Baršić
Aim: To assess the long-term survival after hospital discharge of patients hospitalized due to coronavirus disease 2019 (COVID-19). ----- Methods: We retrospectively reviewed data on post-discharge survival of 2586 COVID-19 patients hospitalized in o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a21ed1b9fe605d0647dfd3bdb10a045b
https://urn.nsk.hr/urn:nbn:hr:105:770849
https://urn.nsk.hr/urn:nbn:hr:105:770849
Autor:
Irzal Hadžibegović, Tomislav Letilović, Stjepan Mesarov, Vedran Radonić, Ivana Jurin, Jelena Lucijanic, Marko Lucijanic, Nikola Zagorec
Publikováno v:
Drugs & Aging. 38:417-425
Objective: Our objective was to investigate the predictors of falls requiring a visit to the emergency department in patients with nonvalvular atrial fibrillation (AF) receiving different types of anticoagulants and to investigate the clinical conseq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8a27bb53c612fa9ebb8899b1860066
https://doi.org/10.1007/s40266-021-00843-9
https://doi.org/10.1007/s40266-021-00843-9
Autor:
Damir Bosnar, Mira Knežić Zagorec, Mladen Bušić, Valentina Cigić, Nikola Zagorec, Tamara Nikuševa Martić, Danica Galešić Ljubanović
Publikováno v:
Translational Vision Science & Technology. 12:25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfc2b1f1e2ce7acc437827112c1bd5f3
https://doi.org/10.1167/tvst.12.5.25
https://doi.org/10.1167/tvst.12.5.25
Autor:
Nikola Zagorec, Ivica Horvatic, Dino Kasumović, Luka Toric, Petar Šenjug, Danica Galešić Ljubanović, Kresimir Galesic
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Rituximab (RTX) showed some efficacy in treatment of minimal change disease (MCD) and primary focal segmental glomerulosclerosis (pFSGS) [1]. The results of its off-label use and as steroid-sparing agent were especially promising
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5d451576977de9997a16f28d68ab046
https://doi.org/10.1093/ndt/gfac067.036
https://doi.org/10.1093/ndt/gfac067.036
Autor:
Nikola Zagorec, Dragan Klarić, Marta Klarić, Ivica Horvatić, Petar Šenjug, Matija Horaček, Jagoda Nikić, Danica Galešić Ljubanović, Krešimir Galešić
Collapsing glomerulopathy (CG) or collapsing focal segmental glomerulosclerosis (cFSGS) is an aggressive disease with a high tendency of progression to end-stage renal disease due to common resistance to conventional immunosuppressants. Rituximab (RT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d82714135618a117db9993d030bf0cf2
https://doi.org/10.3390/jpm12091415
https://doi.org/10.3390/jpm12091415